These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine. Bei R; Mizejewski GJ Curr Mol Med; 2011 Oct; 11(7):564-81. PubMed ID: 21707514 [TBL] [Abstract][Full Text] [Related]
4. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. Wang X; Wang Q Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice. Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206 [TBL] [Abstract][Full Text] [Related]
6. [Research progress of AFP in the diagnosis and therapy of hepatocellular carcinoma]. Qian L; Li C; Luo Y; Meng S Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3042-3060. PubMed ID: 34622616 [TBL] [Abstract][Full Text] [Related]
7. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein. Chou CK; Hung JY; Liu JC; Chen CT; Hung MC Cancer Gene Ther; 2006 Aug; 13(8):746-52. PubMed ID: 16410824 [TBL] [Abstract][Full Text] [Related]
8. Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma. Nakagawa H; Mizukoshi E; Kobayashi E; Tamai T; Hamana H; Ozawa T; Kishi H; Kitahara M; Yamashita T; Arai K; Terashima T; Iida N; Fushimi K; Muraguchi A; Kaneko S Gastroenterology; 2017 May; 152(6):1395-1406.e10. PubMed ID: 28188748 [TBL] [Abstract][Full Text] [Related]
9. Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver Cancer. Zhao K; Zhou X; Xiao Y; Wang Y; Wen L Mini Rev Med Chem; 2022; 22(17):2237-2243. PubMed ID: 35184712 [TBL] [Abstract][Full Text] [Related]
10. Specific antitumor immunity induced by cross-linking complex heat shock protein 72 and alpha-fetoprotein. Wang XP; Lin HP; Wang QX; Gu Y Cancer Biother Radiopharm; 2012 Apr; 27(3):189-97. PubMed ID: 22372558 [TBL] [Abstract][Full Text] [Related]
12. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Butterfield LH; Economou JS; Gamblin TC; Geller DA J Transl Med; 2014 Apr; 12():86. PubMed ID: 24708667 [TBL] [Abstract][Full Text] [Related]
13. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells. Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295 [TBL] [Abstract][Full Text] [Related]
15. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses. Zuo B; Zhang Y; Zhao K; Wu L; Qi H; Yang R; Gao X; Geng M; Wu Y; Jing R; Zhou Q; Seow Y; Yin H J Hematol Oncol; 2022 Apr; 15(1):46. PubMed ID: 35488312 [TBL] [Abstract][Full Text] [Related]
16. Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials. Sun Z; Zhu Y; Xia J; Sawakami T; Kokudo N; Zhang N Biosci Trends; 2016 May; 10(2):85-91. PubMed ID: 26522694 [TBL] [Abstract][Full Text] [Related]
17. Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. Lu X; Deng S; Xu J; Green BL; Zhang H; Cui G; Zhou Y; Zhang Y; Xu H; Zhang F; Mao R; Zhong S; Cramer T; Evert M; Calvisi DF; He Y; Liu C; Chen X J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37040183 [TBL] [Abstract][Full Text] [Related]
18. Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma. Hirai H; Taketa K J Chromatogr; 1992 Jun; 604(1):91-4. PubMed ID: 1379253 [TBL] [Abstract][Full Text] [Related]
19. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
20. Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma. Sadeghlar F; Seelemann J; Vogt A; Möhring C; Zhou T; Mahn R; Kornek M; Lukacs-Kornek V; Casares N; Lasarte JJ; Sarobe P; van Beekum C; Matthaei H; Manekeller S; Kalff J; Schmidt-Wolf IGH; Strassburg CP; Gonzalez-Carmona MA Immunol Invest; 2023 Nov; 52(8):966-984. PubMed ID: 37846958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]